Complete blood count
Diagnostic TestStudy haemtological disturbances in neonates with necrotizing enterocolities
NCT Number: NCT06632041
Haematological disturbances in neonates with necrotizing enterocolities
Trial opening soon.
Get Notified1 day–30 day
All sexes
Observational
Necrotizing enterocolitis (NEC) is an acquired, multifactorial and devastating gastrointestinal disease associated with high morbidity and mortality in preterm neonates. With an incidence of about 7% in infants with BW < 1500 g and mortality up to 30%, NEC presents as a medical and surgical emergency It is characterized by ischemia, necrosis, and inflammation of bowel wall with invasion by gas-forming organisms and intramural dissection of gas ,characteristicall appearing as pneumatosis intestinalis in radiological and pathological studies. While exact etiology is undetermined, the pathogenesis is believed to be an anomalous innate immune response to an altered, less diverse intestinal microbiota by the highly immunoreactive enterocytes of premature infants, leading to inflammation and tissue necrosis
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Study haemtological disturbances in neonates with necrotizing enterocolities
Haemtological disturbances in neonates with necrotizing enterocolities
Time frame: Baseline
:to delineate haemtological abnormalities in neonatal necrotizing enterocolities as predictors of morbidity and mortality
Contact information is provided by the study sponsor or research team.
Assiut University
Other
Haematological Disturbances in Neonates with Necrotizing Enterocolities
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03997266
Communicable Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Mobile, Alabama, United States
View Trial DetailsNCT07296718
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Feeding Intolerance
Bahawalpur, Punjab Province, Pakistan
View Trial DetailsNCT05710575
Female Urogenital Diseases and Pregnancy Complications, Necrotizing Enterocolitis of Newborn
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07152106
Chorioamnionitis, Chorioamnionitis Affecting Fetus or Newborn
Amsterdam, Netherlands
View Trial Details